Lafayette, Indiana Clinical Trials

Adenocarcinoma

Research Site

A clinical trial to evaluate treatments using MM-121, Docetaxel and Pemetrexed for patients

Horizon Oncology Research, Inc

A clinical research study for the treatment of Renal Cell Carcinoma (RCC), Urothelial Carcinoma, Gastric Adenocarcinoma or Colorectal Adenocarcinoma (CRC)

Indiana University Health Arnett Hospital

Patients are needed to participate in a clinical research study of BBI608, Nab-paclitaxel and Gemcitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Breast Cancer

Research Site

A Phase 1 clinical study for patients with Advanced Cancer/Advanced Malignancies

Chronic Lymphocytic Leukemia

Indiana University Health Arnett Inc Updated

ACE-CL-007: Study of Obinutuzumab + Chlorambucil, ACP-196 + Obinutuzumab, and ACP-196 Monotherapy in Subjects With Previously Untreated CLL

Indiana University Health Arnett Inc

ACE-CL-007: Study of Obinutuzumab + Chlorambucil, ACP-196 + Obinutuzumab, and ACP-196 Monotherapy in Subjects With Previously Untreated CLL

View More »

Arnett Cancer Care

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Horizon Oncology Research, Inc

Patients are needed to participate in a clinical research study for the treatment of Chronic Lymphocytic Leukemia (CLL)

Chronic Pain

Lafayette Clinical Research Group Updated

A clinical trial to evaluate treatments for patients with Low Back Pain, Chronic

Clostridium Difficile-Associated Diarrhea

Research Site

A Phase 2 clinical study for patients with Clostridium Difficile Infection

Colorectal Cancer

Research Site

A Phase 1 clinical study for patients with Advanced Cancer/Advanced Malignancies

Site Reference ID/Investigator# 138022

A Phase 1 clinical study for patients with Advanced Solid Tumors

Digestive System Neoplasms

Indiana University Health Arnett Hospital

Patients are needed to participate in a clinical research study of BBI608, Nab-paclitaxel and Gemcitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Fallopian Tube Cancer

Horizon BioAdvance

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Heart Failure

Research Site Updated

Patients are needed to participate in a clinical research study of Rivaroxaban, 10 mg, Rivaroxaban, 7.5 mg and Placebo

Leukemia

Indiana University Health Arnett Inc

ACE-CL-007: Study of Obinutuzumab + Chlorambucil, ACP-196 + Obinutuzumab, and ACP-196 Monotherapy in Subjects With Previously Untreated CLL

View More »

Research Site

A Phase 1 clinical study for patients with Advanced Cancer/Advanced Malignancies

Arnett Cancer Care

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Horizon Oncology Center

A clinical trial seeking patients for a research study for the treatment of Acute Leukemia (AML), Myelodysplastic Syndrome (MDS) or Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)

Horizon Oncology Research, Inc

Patients are needed to participate in a clinical research study for the treatment of Chronic Lymphocytic Leukemia (CLL)

Lymphocytic Leukemia, Chronic

Indiana University Health Arnett Inc Updated

ACE-CL-007: Study of Obinutuzumab + Chlorambucil, ACP-196 + Obinutuzumab, and ACP-196 Monotherapy in Subjects With Previously Untreated CLL

Lymphoma

Research Site

A clinical research study of Bendamustine, Obinutuzumab, Polatuzumab Vedotin and Rituximab for the treatment of Lymphoma, Lymphoma B-Cell, Non-Hodgkin's or Follicular Lymphoma

Research Site

A Phase 1 clinical study for patients with Advanced Cancer/Advanced Malignancies

Horizon Bio Advance

A clinical trial seeking patients for a research study for the treatment of Diffuse Large B Cell Lymphoma

Horizon Oncology Center

A clinical trial seeking patients for a research study for the treatment of B-Cell Lymphoma

Horizon Oncology Research, Inc.

A clinical trial to evaluate treatments using LAM-002A for patients with Lymphoma, Non-Hodgkin

Lymphoma, B-Cell

Research Site

A clinical research study of Bendamustine, Obinutuzumab, Polatuzumab Vedotin and Rituximab for the treatment of Lymphoma, Lymphoma B-Cell, Non-Hodgkin's or Follicular Lymphoma

Horizon Bio Advance

A clinical trial seeking patients for a research study for the treatment of Diffuse Large B Cell Lymphoma

Horizon Oncology Center

A clinical trial seeking patients for a research study for the treatment of B-Cell Lymphoma

Multiple Myeloma

IU Health Arnett Cancer Center

A clinical trial to evaluate treatments for patients with Multiple Myeloma

Myelofibrosis

Horizon Oncology Center

A clinical trial seeking patients for a research study for the treatment of Acute Leukemia (AML), Myelodysplastic Syndrome (MDS) or Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)

Neoplasms

Horizon Oncology Center

A clinical trial seeking patients for a research study for the treatment of Acute Leukemia (AML), Myelodysplastic Syndrome (MDS) or Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)

Non-Hodgkin's Lymphoma

Horizon Oncology Research, Inc.

A clinical trial to evaluate treatments using LAM-002A for patients with Lymphoma, Non-Hodgkin

Non-Small Cell Lung Cancer

Research Site

A clinical trial to evaluate treatments using MM-121, Docetaxel and Pemetrexed for patients

Research Site

A Phase 1 clinical study for patients with Advanced Cancer/Advanced Malignancies

Horizon Oncology Updated

A Phase 1 clinical study for patients with Non-Small Cell Lung Cancer

Ovarian Cancer

Horizon BioAdvance

A clinical trial to evaluate treatments using EC1456 and EC20 for patients with advanced solid tumors

Horizon BioAdvance

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Pancreatic Cancer

Indiana University Health Arnett Hospital

Patients are needed to participate in a clinical research study of BBI608, Nab-paclitaxel and Gemcitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Peritoneal Cancer

Horizon BioAdvance

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Prostate Cancer

Research Site

Patients are needed to participate in a clinical research study of Enzalutamide and Placebo to evaluate Nonmetastatic Castration-Resistant Prostate Cancer

Solid Tumors

Horizon BioAdvance

A clinical trial to evaluate treatments using EC1456 and EC20 for patients with advanced solid tumors

Squamous Cell Carcinoma

Research Site

A clinical trial to evaluate treatments using MM-121, Docetaxel and Pemetrexed for patients

Thromboembolism

Research Site Updated

Patients are needed to participate in a clinical research study of Rivaroxaban, 10 mg, Rivaroxaban, 7.5 mg and Placebo